Denosumab: AHFS 92:24.

J Pain Symptom Manage

University of Nottingham (A.W.), Nottingham, United Kingdom; University Hospitals (S.C.), Nottingham, United Kingdom; Countess Mountbatten House (C.S.T), University Hospital Southampton; University of Nottingham (R.G.), Nottingham, United Kingdom; Mylan School of Pharmacy (M.M.), Duquesne University, Pittsburgh, Pennsylvania, USA and Mountbatten Hospice (P.H.), Isle of Wight, United Kingdom.

Published: August 2018

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2018.05.021DOI Listing

Publication Analysis

Top Keywords

palliative care
8
care formulary
8
denosumab ahfs
4
ahfs 9224
4
9224 therapeutic
4
therapeutic reviews
4
reviews aim
4
aim provide
4
provide essential
4
essential independent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!